GW Pharma (GWPH) Posts Smaller-than-Expected Q1 Loss

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($0.77), $0.92 better than the analyst estimate of ($1.69). Revenue for the quarter came in at $2.54 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c